GEN - Genetic Engineering and Biotechnology News9d
From Tools to Trials: Editing Therapy Companies Pivot to Development
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
pharmaphorum4y
Lilly pays up to $1.04bn for neurology gene therapy biotech Prevail
Eli Lilly has acquired Prevail, a biotech focusing on gene therapies for neurodegenerative diseases including Parkinson's, in a deal potentially worth more than $1 billion. The big US pharma is to ...